113 related articles for article (PubMed ID: 3145170)
21. Two-year follow-up of changes in clinical chemistry in Singaporean Norplant-2 rod acceptors: haemostatic changes.
Singh K; Viegas OA; Koh S; Singh P; Ratnam SS
Contraception; 1989 Feb; 39(2):155-64. PubMed ID: 2495890
[TBL] [Abstract][Full Text] [Related]
22. Lipid and biochemical changes after low-dose oral contraception.
Loke DF; Ng CS; Holck S; Hall PE; Ratnam SS
Contraception; 1992 Sep; 46(3):227-41. PubMed ID: 1451519
[TBL] [Abstract][Full Text] [Related]
23. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of liver function and lipid metabolism following Norplant-2 rods removal.
Singh K; Viegas OA; Loke DF; Ratnam SS
Adv Contracept; 1993 Sep; 9(3):233-9. PubMed ID: 8237578
[TBL] [Abstract][Full Text] [Related]
25. Norplant-2 subdermal contraceptive system: experience in Taiwan.
Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
[TBL] [Abstract][Full Text] [Related]
26. Two-year follow-up of changes in clinical chemistry in Singaporean Norplant acceptors: haemostatic changes.
Singh K; Viegas OA; Koh S; Singh P; Ratnam SS
Contraception; 1989 Feb; 39(2):137-46. PubMed ID: 2495888
[TBL] [Abstract][Full Text] [Related]
27. The effects of Norplant-2 rods on clinical chemistry in Singaporean acceptors after 1 year of use: haemostatic changes.
Singh K; Viegas OA; Koh S; Singh P; Ratnam SS
Contraception; 1988 Oct; 38(4):441-51. PubMed ID: 3145169
[TBL] [Abstract][Full Text] [Related]
28. Carbohydrate metabolism before and after Norplant removal.
Konje JC; Odukoya OA; Otolorin EO; Ewings PD; Ladipo OA
Contraception; 1992 Jul; 46(1):61-9. PubMed ID: 1424624
[TBL] [Abstract][Full Text] [Related]
29. Norplant-2 rods: one year experience in Singapore.
Singh K; Viegas OA; Liew D; Singh P; Ratnam SS
Contraception; 1988 Oct; 38(4):429-40. PubMed ID: 3145168
[TBL] [Abstract][Full Text] [Related]
30. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
[TBL] [Abstract][Full Text] [Related]
31. Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: differential changes in high-density lipoprotein subclasses.
Krauss RM; Roy S; Mishell DR; Casagrande J; Pike MC
Am J Obstet Gynecol; 1983 Feb; 145(4):446-52. PubMed ID: 6401927
[TBL] [Abstract][Full Text] [Related]
32. Clinical chemistry and pituitary response changes in Egyptian acceptors of L. Norgestrel six rods implants during the first year of use.
Abdel-sayed WS; Toppozada MK; Rizk MA; El-sahwy MS; Haiba NA
Alex J Pharm Sci; 1989 Sep; 3(2):134-7. PubMed ID: 12283153
[TBL] [Abstract][Full Text] [Related]
33. Glucose and lipid metabolism with triphasic oral contraceptives in women with history of gestational diabetes.
Kung AW; Ma JT; Wong VC; Li DF; Ng MM; Wang CC; Lam KS; Young RT; Ma HK
Contraception; 1987 Mar; 35(3):257-69. PubMed ID: 3111786
[TBL] [Abstract][Full Text] [Related]
34. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of the metabolic effects of injectable and oral contraceptives.
Liew DF; Ng CS; Heng SH; Ratnam SS
Contraception; 1986 Apr; 33(4):385-94. PubMed ID: 2942334
[TBL] [Abstract][Full Text] [Related]
36. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
[TBL] [Abstract][Full Text] [Related]
37. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
Olsson SE; Odlind V; Johansson ED; Nordström ML
Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
[TBL] [Abstract][Full Text] [Related]
38. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.
Sheu WH; Hsu CH; Chen YS; Jeng CY; Fuh MM
Clin Endocrinol (Oxf); 1994 Feb; 40(2):249-55. PubMed ID: 8137525
[TBL] [Abstract][Full Text] [Related]
39. Acceptability of Norplant-2 rods as a method of family planning.
Singh K; Viegas OA; Ratnam SS
Contraception; 1992 May; 45(5):453-61. PubMed ID: 1623717
[TBL] [Abstract][Full Text] [Related]
40. Changes in carbohydrate metabolism during 30 months on Norplant.
Konje JC; Otolorin EO; Ladipo OA
Contraception; 1991 Aug; 44(2):163-72. PubMed ID: 1909945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
